David Ball

Mid-treatment adaptive planning during thoracic radiation using 68 Ventilation-Perfusion Positron emission tomography.

Nicholas Bucknell, Nicholas Hardcastle, Roshini Gunewardena, Long Nguyen, Jason Callahan, David Ball, Lisa Selbie, Tomas Kron, Guy-Anne Turgeon, Michael S Hofman, Shankar Siva

Journal article  |  2023  |  Clin Transl Radiat Oncol

UNLABELLED: Four-Dimensional Gallium 68 Ventilation-Perfusion Positron Emission Tomography (68Ga-4D-V/Q PET/CT) allows for dynamic..

Cost-Effectiveness of Single Versus Multifraction SABR for Pulmonary Oligometastases: The SAFRON II Trial.

Richard De Abreu Lourenco, Terence Khoo, Anna Crothers, Marion Haas, Rebecca Montgomery, David Ball, Mathias Bressel, Shankar Siva

Journal article  |  2022  |  Int J Radiat Oncol Biol Phys

PURPOSE: The use of stereotactic ablative body radiation therapy (SABR) in advanced cancer care is increasing, yet the cost-effect..

Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases

Shankar Siva, Gavin Jones, Mathias Bressel, Mark Shaw, Sarat Chander, Julie Chu, Nikki Plumridge, Keelan Byrne, Gargi Kothari, Nicholas Hardcastle, Mathieu Gaudreault, Tomas Kron, Greg Wheeler, Michael MacManus, Gerard G Hanna, David L Ball, Steven David

Journal article  |  2022  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

PURPOSE: Medical operability is prognostic for survival after SABR in primary malignancies. This study investigated the prognostic..

EP05.01-023 Feasibility of Functional Lung Avoidance using Ga-68 4D Ventilation Perfusion PET/CT: The HI-FIVE Trial

NW Bucknell, N Hardcastle, B Woon, M Bressel, K Byrne, L Selbie, J Callahan, GG Hanna, MS Hofman, D Ball, T Kron, S Siva

Journal article  |  2022  |  Journal of Thoracic Oncology

Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: An application of the TARGET-TP score.

Kate Burbury, Marliese Alexander, Samuel J Harris, Craig Underhill, Javier Torres, Sharad Sharma, Nora Lee, Hui-Li Wong, Richard Wilhelm Eek, Michael Michael, Jeanne Tie, Jennifer Rogers, Alexander Graham Heriot, David Ball, Michael Patrick MacManus, Rory Wolfe, Benjamin J Solomon

Conference Proceedings  |  2022  |  Journal of Clinical Oncology

12116 Background: Interventional trials applying risk models for targeted-thromboprophylaxis (TP) for ambulatory cancer patients ..

Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial

M Alexander, SJ Harris, C Underhill, J Torres, S Sharma, N Lee, H Wong, R Eek, M Michael, J Tie, J Rogers, A Heriot, D Ball, M MacManus, R Wolfe, B Solomon, K Burbury

Conference Proceedings  |  2022  |  THROMBOSIS RESEARCH

The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the r..

Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET-TP score

M Alexander, SJ Harris, C Underhill, J Torres, S Sharma, N Lee, H Wong, R Eek, M Michael, J Tie, J Rogers, A Heriot, D Ball, M MacManus, R Wolfe, B Solomon, K Burbury

Conference Proceedings  |  2022  |  THROMBOSIS RESEARCH

The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the r..

Impact of operability and total metastatic ablation on outcomes after SABR for oligometastases

S Siva, M Bressel, P Sogono, M Shaw, S Chander, J Chu, N Plumridge, K Byrne, G Kothari, N Bucknell, N Hardcastle, T Kron, G Wheeler, M MacManus, GG Hanna, DL Ball, S David

Conference Proceedings  |  2022  |  RADIOTHERAPY AND ONCOLOGY

The therapeutic relevance of a BRCA2 mutation in a patient with recurrent thymoma: a case report.

Samantha Sigurdson, Edith M Marom, Andreas Rimner, Annemarie Shepherd, Malgorzata Szolkowska, Anja C Roden, Mirella Marino, Noriyuki Tomiyama, David Ball, Conrad Falkson, Arun Rajan

Journal article  |  2022  |  Mediastinum

BACKGROUND: Thymomas are characterized by a low tumor mutation burden and a paucity of actionable mutations. Clinical behavior can..

Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort study

Tiffany Lin, Jonathan Pham, Eldho Paul, Matthew Conron, Gavin Wright, David Ball, Paul Mitchell, Nicola Atkin, Margaret Brand, John Zalcberg, Robert G Stirling

Journal article  |  2022  |  LUNG CANCER

INTRODUCTION: Multidisciplinary Meetings (MDM) are recommended in routine lung cancer care, however its broader impacts demand fur..